Skip to content

LOINC Result Terms Value set

Canonicalhttps://fhir.apps.health/ValueSet/nexus-loinc-result
Statusdraft · 1.33.0
SourceFSH · JSON

Every LOINC term that can code a reported result, for Observation.code: the terms whose ORDER_OBS property is Observation, Both or Subset, excluding the LOINC Document Ontology, claims attachments and deprecated terms.

What is in, and why. Observation and Both terms are reported. Subset terms are in because the members of a panel are reported as results even where the panel is only ordered. Surveys (CLASSTYPE 4) are in: a scored instrument such as a depression or anxiety screen is recorded as an Observation, and its score is a result. Report-level terms such as imaging reports are in, because they are what a result report is coded with.

What is out, and why. The LOINC Document Ontology is out: a clinical document kind is not a result (it is matched by CLASS = LP32519-8, the Part for the Document Ontology class). Claims attachments (CLASSTYPE 3) are out: they qualify an attachment sent with a claim. Terms with no ORDER_OBS value are not members.

Laboratory results in Canada. The pan-Canadian LOINC Observation Code Database, served under https://fhir.infoway-inforoute.ca/CodeSystem/pCLOCD, is the Canadian subset for laboratory results (see pan-Canadian LOINC Properties). This set is not limited to it, because results also include vital signs and clinical observations.

Defined, not enumerated. The set is a filter on LOINC's own properties, so its membership follows the LOINC release the terminology service holds and needs no release of this guide. It carries no expansion; $expand it against the terminology service.

Definition

Includes

  • Codes from LOINC where ORDER_OBS is Observation, Both or Subset

Excludes

  • Codes from LOINC where CLASS is LP32519-8
  • Codes from LOINC where CLASSTYPE is 3
  • Codes from LOINC where STATUS is DEPRECATED

Codes

This set has 85,065 codes, as the terminology service expands it. 500 are shown below, spread evenly across the code range; this page is not the expansion.

Displays from version 2.83.

The sample is drawn from the 80,960 of them that may be reproduced here; 4,105 carrying a third-party copyright notice are counted but not shown.

Attribution required by the publisher

This material contains content from LOINC (https://loinc.org). LOINC is copyright (c) 1995+ Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the LOINC licence (https://loinc.org/license). LOINC(R) is a registered United States trademark of Regenstrief Institute, Inc. Terms carrying a third-party copyright notice are not reproduced here.

Code Display
1-8 Acyclovir [Susceptibility]
100162-7 Knee alignment W standing X-ray measured
100334-2 Been physically hurt with some degree of injury
100686-5 JC virus DNA [Log #/volume] (viral load) in Cerebrospinal Fluid by NAA with probe detection
100862-2 Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
101089-1 Ge3 Ag [Presence] on Red Blood Cells
101252-5 Urea [Mass/volume] in Dialysis fluid
101420-8 Human coronavirus HKU1 RNA [Presence] in Respiratory system specimen by NAA with probe detection
101588-2 Histoplasma capsulatum+Blastomyces dermatitidis Ag [Presence] in Serum or Plasma by Immunoassay
101774-8 Microsporum ferrugineum DNA [Presence] in Specimen by NAA with probe detection
101993-4 Kynurenate/Creatinine [Mass Ratio] in Urine
102186-4 Blueberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
102340-7 Kentucky blue grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
102486-8 Papaya (Carica papaya) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
102647-5 Walnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
102807-5 Rice IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
102968-5 Trichophyton sp IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
103127-7 Honey bee recombinant (rApi m) 10 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
103297-8 XR Cervical spine GE 3 Views
103442-0 XR Wrist - right and Hand - right GE 3 Views
103619-3 Coagulation surface induced.lupus sensitive.buffer (LA control) in Platelet poor plasma by Coagulation assay
103832-2 Naloxone [Presence] in Meconium
1040-5 G Ag [Presence] on Red Blood Cells from Donor
104192-0 Guanidinoacetate methyltransferase deficiency newborn screen interpretation
10435-6 C5B-9 Ag [Presence] in Tissue by Immune stain
104521-0 T little c super little c Ab [Presence] in Serum or Plasma
104735-6 Influenza virus B RNA [Presence] in Specimen by Molgen
104891-7 Communication aid Person Narrative
105047-5 Clostridioides difficile presence and susceptibility in Specimen Document by Organism specific culture
10522-1 Coagulation factor XIII Ag [Presence] in Tissue by Immune stain
105521-9 Breastfeeding start date
105694-4 Nakaseomyces nivariensis DNA [Presence] in Specimen by NAA with probe detection
105880-9 Cytomegalovirus DNA [Units/volume] in Serum or Plasma
10603-9 Spermatozoa Abnormal Midpiece/Spermatozoa in Semen
106289-2 US Guidance for injection of Tendon
106460-9 How much suffering do you experience because of your pain
106627-3 Width palpebral fissure opening [Length] in Eye from Fetus
106795-8 Ganglioside GT1a IgM Ab [Presence] in Serum by Immunoassay
106975-6 Dihydroboldenone [Presence] in Urine by Gas chromatography-mass spectrometry
107164-6 Weight [Mass] Kidney - bilateral
107337-8 Amikacin [Susceptibility] liposome inhaled breakpoints by Minimum inhibitory concentration (MIC)
107516-7 N-Desethyl Isotonitazene [Mass/volume] in Urine by Confirmatory method
107702-3 Lamb meat IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
107854-2 Cayenne IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
108068-8 Amaranth IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
108233-8 Social network note
10945-4 Papain IgE Ab [Units/volume] in Serum
11094-0 Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma
111589-8 Left eye Performed Protocol Pattern [Units/mass] Static Automated Perimetry
111748-0 Wind velocity
111903-1 Number of approaches to papilla until deep cannulation Biliary duct and Pancreatic duct Endoscopy
112049-2 Endoscopic procedure Minor papilla Endoscopy
112209-2 Red mulberry IgE Ab [Units/volume] in Serum or Plasma by Immunoassay
112452-8 Did a parent or adult in your home ever swear at you, insult you, or put you down
112612-7 Expanded Food Security Screener Priority Level [FSS-Exp]
112786-9 Platelet aggregation in Platelet rich plasma by Aggregometry.adenosine diphosphate induced.1.0 umol/L
112953-5 Walnut (Juglans regia recombinant) rJug r 4 IgE Ab [Units/volume] in Serum or Plasma by Immunoassay
113186-1 Flualprazolam/Creatinine [Mass Ratio] in Urine
113350-3 JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine
113516-9 Tricyclic antidepressants [Presence] in Urine by Immunoassay>300 ng/mL
113677-9 oxyCODONE [Mass/volume] in Saliva (oral fluid) by Mass Spectrometry
113837-9 Methadone [Presence] in Blood by Immunoassay
113998-9 HYDROcodone [Presence] in Saliva (oral fluid) by Mass Spectrometry
114156-3 chlordiazePOXIDE [Presence] in Urine by Immunoassay
114316-3 Methamphetamine+Methylenedioxymethamphetamine [Presence] in Body fluid by Immunoassay
114513-5 Western equine encephalitis virus RNA [Presence] in Specimen by Molgen
114673-7 Rotavirus C RNA [Presence] in Specimen by Molgen
114821-2 Mycobacterium sp DNA [Presence] in Specimen by Molgen
114980-6 Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Specimen by Molgen
115139-8 Enterobacter hormaechei DNA [Presence] in Specimen by Molgen
115288-3 Candida auris ITS2 gene [Presence] in Specimen by Molgen
115446-7 Adenovirus 3+4+7+21 DNA [Presence] in Specimen by Molgen
115768-4 Posaconazole --trough [Mass/volume] of Serum
11702-8 Cerebral artery middle Peak systolic flow velocity US.doppler
11863-8 Fetal Cerebellum Diameter transverse US
12019-6 Fetal Umbilical artery at placenta Resistivity index US.doppler
12170-7 Fetal Head Hemisphere width US
12328-1 Beta blockers [Identifier] in Urine
12487-5 Butalbital [Presence] in Gastric fluid
12636-7 Glucose [Mass/volume] in Peritoneal dialysis fluid --7th specimen
12793-6 Oxalate [Mass/volume] in Urine --5th specimen post XXX challenge
12948-6 Thyrotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge
1316-9 S Ab [Presence] in Serum or Plasma from Donor
13318-1 Escherichia coli enteroinvasive identified in Stool by Organism specific culture
13471-8 Cadmium/Creatinine [Mass Ratio] in Urine
13627-5 Erythrocytes [Presence] in Semen by Light microscopy
13778-6 Mevalonate/Creatinine [Mass Ratio] in Urine
13933-7 Benzodiazepines [Mass/mass] in Hair
14084-8 Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence
14238-0 Myelin basic protein IgG Ab [Units/volume] in Serum
14390-9 Amylase [Enzymatic activity/volume] in Dialysis fluid
14542-5 Measles virus Ag [Presence] in Urine sediment by Immunofluorescence
14693-6 Norclobazam [Moles/volume] in Serum or Plasma
1484-5 Gastrin [Mass/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin
14989-8 little i-2 subtype [Presence] on Red Blood Cells from Blood product unit
1514-9 Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO
15292-6 Testis - left Height by US
15443-5 Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID)
16129-9 Hepatitis C virus IgG Ab [Presence] in Serum
16279-2 Toxoplasma gondii DNA [Presence] in Blood by NAA with probe detection
16451-7 Beryllium [Presence] in Urine
16609-0 Chlorphentermine [Units/volume] in Blood
16765-0 Dichlorodiphenyltrichloroethane [Mass/volume] in Milk
16928-4 Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum
17079-5 Fatty acids.long chain [Identifier] in Serum or Plasma
17229-6 Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebrospinal Fluid
1739-2 Alanine [Mass/time] in 24 hour Urine
1754-1 Albumin [Mass/volume] in Urine
17727-9 Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence
17878-0 Bacteria # 2 identified in Bronchial specimen by Aerobe culture
18025-7 Heart Diameter anterior-posterior systole/Aortic root diameter by US
18173-5 Pulmonary artery Blood velocity-time integral by US.doppler
18333-5 Echovirus 7 Ab [Units/volume] in Cerebrospinal Fluid
18483-8 Yeast [Presence] in Genital specimen by Organism specific culture
18860-7 Amikacin [Susceptibility]
19023-1 Granulocytes/Leukocytes in Blood by Automated count
19233-6 Bicarbonate [Moles/volume] standard in Mixed venous blood
19391-2 Chlorpheniramine [Mass/volume] in Urine by Confirmatory method
19557-8 Methamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
19732-7 Cat serum albumin IgE Ab [Units/volume] in Serum
20189-7 Ventricular Cardiac index by US.cubed.calculated
20341-4 Time/Time 2 by US
20493-3 Histiocytes/cells in Body fluid by Light microscopy
20655-7 Proline [Moles/volume] in Serum or Plasma
20809-0 Ergot alkaloid [Mass/mass] in Feed
20964-3 Shigella sp identified in Feed by Organism specific culture
2116-2 Choriogonadotropin.intact [Presence] in Serum or Plasma
2137-8 Coproporphyrin [Mass/time] in 24 hour Urine
21592-1 Varicella zoster virus Ab [Titer] in Cerebrospinal Fluid
21759-6 FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method
22120-0 Borrelia burgdorferi Ab [Units/volume] in Body fluid
22271-1 Echovirus 16 Ab [Titer] in Serum
22426-1 Mycoplasma pneumoniae IgG Ab [Titer] in Serum
22603-5 Varicella zoster virus IgG Ab [Units/volume] in Serum --1st specimen
22767-8 African horse sickness virus Ab [Presence] in Serum by Immunoblot
22916-1 Bovine leukemia virus Ab [Presence] in Milk by Immunoassay
23067-2 Epizootic hemorrhagic disease virus RNA [Presence] in Blood by NAA with probe detection
23212-4 Lumpy skin disease virus [Presence] in Tissue by Electron microscopy
23364-3 Porcine enterovirus Ag [Presence] in Specimen by Immunofluorescence
23520-0 Trypanosoma evansi [Presence] in Aspirate by Wet preparation
23683-6 Brucella canis Ab [Titer] in Serum by Immunofluorescence
23836-0 Carbon disulfide [Mass/volume] in Serum or Plasma
24001-0 Ganglioside GQ1b IgG Ab [Titer] in Cerebrospinal Fluid by Immunoassay
24171-1 Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
24381-6 Platelet aggregation interpretation in Platelet rich plasma Qualitative Induced by Arachidonate
24541-5 XR Ankle Views
24698-3 RFA Guidance for angioplasty of Femoral artery-- W contrast IA
24867-4 MR Pelvis
25034-0 RF Wrist Arthrogram
25190-0 Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 8.0 ug/mL
25364-1 Campylobacter jejuni Ab [Titer] in Serum by Complement fixation
25538-0 Thermoactinomyces vulgaris IgG Ab [Units/volume] in Serum
25712-1 Leptospira interrogans sv Pomona Ab [Titer] in Serum by Complement fixation
25877-2 Citrulline [Moles/volume] in 24 hour Urine
26029-9 Lactoferrin bovine IgE Ab [Units/volume] in Serum
2619-5 Methemoglobin [Presence] in Red Blood Cells
26338-4 MG Guidance for biopsy of Breast - left
26511-6 Neutrophils/Leukocytes in Blood
26664-3 Chlamydia trachomatis E Ab [Presence] in Serum
26815-1 Cocaethylene [Mass/mass] in Meconium
26968-8 Beta alanine [Moles/volume] in Urine
27120-5 Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --2nd specimen
27291-4 Hydroxylysine [Moles/volume] in Urine
2757-3 Phenol [Mass/volume] in Blood
27939-8 Collagen crosslinked N-telopeptide [Moles/volume] in Urine
2825-8 Potassium [Moles/volume] in Saliva (oral fluid)
28926-4 Right contact lens prescription Explanation [Interpretation]
29282-1 Glutethimide [Presence] in Gastric fluid
29447-0 Left ventricular posterior wall Thickening.fractional change by US.M-mode
29624-4 3-Hydroxyglutarate [Presence] in Urine
29777-0 Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunoassay
29926-3 Boron [Mass/volume] in 24 hour Urine
30074-9 Hemoglobin F [Presence] in Specimen
30222-4 Coxsackievirus B3 Ab [Presence] in Serum
30375-0 Basophils/Leukocytes in Sputum
30536-7 Magnesium [Mass/volume] in Total parental nutrition
30690-2 MR Upper arm WO and W contrast IV
30846-0 RFA Renal vein - bilateral Views W contrast IV
310-3 Lymecycline [Susceptibility] by Minimum lethal concentration (MLC)
31150-6 ERBB2 gene duplication [Presence] in Tissue by FISH
31302-3 Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum
31461-7 Legionella pneumophila 4 Ab [Units/volume] in Serum
31611-7 Rickettsia typhi IgM Ab [Units/volume] in Body fluid
31780-0 Chlamydophila psittaci Ag [Presence] in Specimen
31929-3 Parainfluenza virus Ag [Presence] in Specimen
32076-2 Glutethimide [Moles/volume] in Serum or Plasma
32221-4 Alanine [Moles/volume] in Vitreous fluid
32372-5 Fleroxacin [Susceptibility]
32603-3 Itraconazole [Susceptibility]
32757-7 BCL2 cells/cells in Specimen
33006-8 Cytomegalovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
33157-9 Fetal Head Diameter.biparietal/Diameter.occipital estimated from gestational age by method of Chitty 1994 (US)
3332-4 Amitriptyline [Presence] in Serum or Plasma
33501-8 Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO
33657-8 Beta-N-acetylhexosaminidase.A [Moles/volume] in Leukocytes
33813-7 Insulin [Units/volume] in Serum or Plasma --14th specimen post XXX challenge
33963-0 Granulocytes/Leukocytes in Cerebrospinal Fluid
34231-1 Aldosterone/Creatinine [Molar ratio] in Urine
34379-8 Teicoplanin [Mass/volume] in Serum or Plasma --trough
3455-3 Chloramphenicol [Mass/volume] in Serum or Plasma
34717-9 Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence
3502-2 Clostebol [Presence] in Urine
35182-5 Docosatetraenoate (C22:4w6) [Moles/volume] in Serum or Plasma
35329-2 pH of Body fluid--2nd specimen post Sincalide
35479-5 Diazinon [Mass/volume] in Urine
35657-6 Urea nitrogen/Body weight [Mass/kg/time] in 24 hour Urine
35818-4 Grepafloxacin [Susceptibility] by Disk diffusion (KB)
35965-3 CT Elbow - bilateral
36110-5 CT Lumbar spine limited WO contrast
36260-8 CT Lower leg - left W contrast IV
3641-8 Flunitrazepam [Mass/volume] in Urine
36560-1 XR Femur - left Single view
36707-8 XR Humerus - bilateral AP and Lateral
36857-1 MRA Head vessels WO and W contrast IV
37015-5 XR Abdomen PA prone
37168-2 Portable XR Hip Views
37384-5 RFA Vertebral artery Views W contrast IA
37549-3 XR Wrist - bilateral PA and Lateral and Oblique
3770-5 Metenolone [Mass/time] in 24 hour Urine
37848-9 XR Acromioclavicular Joint Zanca
38002-2 XR Chest Single view W inspiration
3817-4 Metoprolol [Mass/volume] in Urine
38343-0 Chlorobenzene [Mass/volume] in Water
38496-6 Retinyl palmitate [Mass/volume] in Serum or Plasma
38643-3 Calcium cyanamide [Mass/volume] in Air
3879-4 Opiates [Presence] in Urine
39001-3 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma
39307-4 Influenza virus A H6 Ab [Titer] in Serum by Hemagglutination inhibition
39456-9 Acetaminophen [Moles/volume] in Urine
39604-4 Mugwort IgE Ab/IgE total in Serum
39759-6 SPECT Guidance limited for localization of tumor
39923-8 NM Heart Gated and Ejection fraction at rest and W radionuclide IV
40072-1 Calcium [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
40218-0 Glucose [Moles/volume] in Serum or Plasma --29 hours post XXX challenge
40366-7 Glucose [Moles/time] in 24 hour Body fluid
40520-9 Macrophages/Leukocytes in Pleural fluid by Manual count
40677-7 Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoassay
40829-4 Ornithine [Presence] in Blood
40992-0 Rhinovirus+Enterovirus Ag [Presence] in Specimen by Immunofluorescence
41139-7 Influenza virus A N4 Ab [Presence] in Serum
41289-0 11-Deoxycortisol [Mass/volume] in Serum or Plasma --post dose metyraPONE
41475-5 Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay
41704-8 Nafcillin [Susceptibility] by Gradient strip
41864-0 Yeast.hyphae [Presence] in Urine by Computer assisted method
42179-2 PLP1 gene duplication [Presence] in Blood or Tissue by Molecular genetics method
4235-8 Enoxacin [Mass] of Dose
42505-8 Hepatitis B virus surface Ag [Presence] in Cerebrospinal Fluid
42696-5 MR Lower leg - bilateral
42886-2 CD52 cells/cells in Bone marrow
43036-3 Feline herpesvirus Ab [Titer] in Serum
43227-8 Ova and parasites identified in Stool by Trichrome stain
43391-2 Bacterial vaginosis score
43573-5 Borrelia burgdorferi IgM Ab [Units/volume] in Cerebrospinal Fluid by Immunoblot
43731-9 Alkaline phosphatase.fetal+lung+lymphocyte [Presence] in Serum or Plasma
43883-8 Ampicillin [Presence] in Serum or Plasma
4403-2 Piperacillin [Mass] of Dose
44184-0 Portable XR Elbow 2 Views
44348-1 Phenylalanine/Creatinine [Mass Ratio] in 24 hour Urine
44497-6 Herpes simplex virus 2 Ag [Presence] in Vaginal fluid
44657-5 Dominant nodule.maximum.dimension in Prostate tumor
44821-7 Leishmania brasilensis IgG Ab [Titer] in Serum by Immunofluorescence
44979-3 Chlamydophila pneumoniae Ab [Presence] in Serum --2nd specimen
45149-2 Ej Ab [Presence] in Serum
45337-3 Bacterial biochemical profile [Identifier] in Isolate by Culture
45956-0 Reason pneumococcal vaccine not received during assessment period [CMS Assessment]
46261-4 HYDROcodone Free [Presence] in Serum or Plasma
46417-2 Prothrombin time (PT) in Capillary blood by Coagulation assay
46780-3 Short-chain acyl-CoA deficiency (SCAD); ethylmalonic encephalopathy; isobutyryl-CoA dehydrogenase deficiency newborn screen interpretation
47087-2 Angiotensinogen [Moles/volume] in Plasma
47235-7 Reagin Ab [Titer] in Specimen by VDRL
47422-1 Aspergillus flavus H Ab [Presence] in Serum
47591-3 C peptide [Moles/volume] in Serum or Plasma --3 minutes post dose glucose
47738-0 Prostate specific Ag [Mass/volume] in Body fluid
47891-7 Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose growth hormone releasing factor
48041-8 Anthraquinone cutoff [Mass/mass] in Stool
48191-1 Monosodium glutamate (MSG) triggered leukotriene release [Mass/volume] by Leukocytes
48341-2 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
48491-5 XR Temporomandibular joint - left Open and Closed mouth
48685-2 Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mL
48866-8 Ehrlichia sp DNA [Presence] in Specimen by NAA with probe detection
49033-4 Menstrual History - Reported
49192-8 Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --2nd specimen
49340-3 Adenovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
49487-2 Nateglinide [Presence] in Serum or Plasma
49640-6 Protein S Ag/Coagulation factor X Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay
4980-9 HLA-DR3 [Presence] in Donor
49954-1 Somatotropin [Units/volume] in Serum or Plasma --4 AM specimen
50101-5 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Cerebrospinal Fluid
50255-9 Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --3rd specimen fasting
50408-4 Protein.abnormal band/Protein.total in Urine by Electrophoresis
50559-4 Hemoglobin [Mass/volume] in Urine by Automated test strip
50748-3 Alpha-2-Macroglobulin/Creatinine [Mass Ratio] in Urine
50897-8 pH of 24 hour Urine by Test strip
51043-8 CD123 blasts/Blasts in Bone marrow
51191-5 Antimony [Mass/volume] in Body fluid
51339-0 CD45 (Lymphs) cells/Cells in Cerebrospinal Fluid
51488-5 Cortisol [Mass/volume] in Saliva (oral fluid) --6th specimen post XXX challenge
51659-1 Hepatitis B virus surface Ag [Presence] in Body fluid
51810-0 Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum by Immunoassay
51994-2 Homovanillate/Creatinine [Mass Ratio] in Urine collected for unspecified duration
52749-9 Etravirine [Susceptibility] by Genotype method
52953-7 Cocaine [Moles/volume] in Urine
53103-8 Decenoylcarnitine (C10:1) [Moles/volume] in Urine
53251-5 Influenza virus B RNA [#/volume] (viral load) in Specimen by NAA with probe detection
53419-8 Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --1st specimen post XXX challenge
53565-8 Platelet aggregation in Platelet rich plasma by ADP induced 100 umol/mL
53718-3 Acylglycines [Interpretation] in Urine Narrative
5388-4 Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
54027-8 Lamin Ab [Presence] in Serum by Immunofluorescence
54270-4 Glucose [Moles/volume] in Serum or Plasma --2.5 hour post dose ornithine alpha-ketoglutarate
54430-4 Pooled platelets given [Volume]
54749-7 Moving from seated to standing position during assessment period [CMS Assessment]
55135-8 BCR-ABL1 kinase domain mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal
55379-2 Snowshoe hare virus IgM Ab [Presence] in Serum by Immunoassay
55581-3 sulfaSALAzine [Moles/volume] in Serum or Plasma
55746-2 How are you today: feeling low or worried
55905-4 Alpha cortol [Mass/volume] in 24 hour Urine
56137-3 LDL 2 [Moles/volume] in Serum or Plasma
56290-0 House dust Greer IgG4 Ab [Mass/volume] in Serum
56436-9 Zucchini IgG4 Ab [Mass/volume] in Serum
56586-1 Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
56734-7 Centromere protein B Ab [Presence] in Serum by Immunoblot
56958-2 Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
57231-3 Stage of most problematic pressure injury during assessment period [CMS Assessment]
57393-1 CD11a cells/cells in Body fluid
57541-5 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post dose gonadotropin releasing hormone
5769-5 Bacteria [#/area] in Urine sediment by Microscopy high power field
57875-7 Cantaloupe IgG4 Ab [Mass/volume] in Serum
58032-4 White Elm IgG Ab [Mass/volume] in Serum
58384-9 6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine
58543-0 Corticotropin [Moles/volume] in Plasma --12 PM specimen
5869-3 Parainfluenza virus 1 Ag [Presence] in Specimen by Immunofluorescence
58849-1 Somatotropin [Mass/volume] in Serum or Plasma --15th specimen
5900-6 Prothrombin Fragment 1.2 [Units/volume] in Serum or Plasma
59214-7 Succinyladenosine/Creatinine [Molar ratio] in Urine
59377-2 2-Methylacetoacetate/Creatinine [Molar ratio] in Urine
59663-5 Diclofenac [Mass/volume] in Urine
5982-4 Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis
59976-1 traZODone [Moles/volume] in Gastric fluid
60121-1 Pancuronium [Mass/volume] in Blood
60276-3 oxyCODONE+oxyMORphone cutoff [Mass/volume] in Urine for Screen method
60430-6 Hepatitis E virus genotype [Identifier] in Blood by NAA with probe detection
60766-3 Gas delivery system inspiratory Isoflurane setting [VFr/PPres]
61023-8 Enflurane gas delivered.total [Volume] in Reporting period from Gas delivery system
61186-3 Spermatozoa thin midpiece/Spermatozoa in Semen
61331-5 Beef IgE Ab/IgE total in Serum
6198-6 Paper wasp IgE Ab [Units/volume] in Serum
62435-3 Saint Louis encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay
63092-1 Cheese cheddar type IgG Ab [Mass/volume] in Serum
63238-0 Extractable nuclear Ab [Presence] in Body fluid by Immunoassay
63387-5 Elastase Ab [Presence] in Body fluid by Immunoassay
6357-8 Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6447-7 Legionella pneumophila Ag [Presence] in Urine by Immunoassay
65354-3 Proinsulin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
66114-0 Stomach Pathology biopsy report
66752-7 Clot strength in Blood by Thromboelastography --after addition of heparinase
67704-7 Feeding types
6841-1 Grape IgE Ab [Units/volume] in Serum
68963-8 Collection date and time of Specimen
69148-5 XR Knee - left Views and Tunnel
69305-1 XR Zygomatic arch 2 Views
6968-2 Proteinase 3 Ab [Units/volume] in Serum
69903-3 Service comment 76
7007-8 Dirithromycin [Susceptibility] by Gradient strip
70265-4 Protein in pericardial fluid/Protein in serum
70951-9 Interdialytic time [ESRD]
71505-2 Date changed ownership Dialysis facility [ESRD]
71695-1 Immature granulocytes/Leukocytes in Blood by Automated count
71877-5 Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood by HPLC
7220-7 Horse Chestnut IgE Ab [Units/volume] in Serum
7238-9 Cocklebur IgG Ab [Units/volume] in Serum
72536-6 US Guidance for vascular sclerotherapy of Extremity veins - bilateral
72729-7 7-Hydroxymitragynine/Creatinine [Mass Ratio] in Urine
72884-0 CYP1A2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
73038-2 Ciprofloxacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73185-1 Pseudoephedrine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73330-3 Ipratropium induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73477-2 Caspofungin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73625-6 cefTAZidime+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC)
73796-5 Infant activity during preductal oxygen saturation measurement
73950-8 JWH-250 (synthetic cannabinoid) [Presence] in Blood
74105-8 Oxygen saturation Calculated from oxygen partial pressure in Mixed venous blood
74328-6 MICA*030 IgG Ab [Presence] in Serum
74487-0 P504S and p63 and Cytokeratin 903 Ag [Identifier] in Tissue by Immune stain
74646-1 Methamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
74820-2 Plasma cells.centrocytes/Leukocytes in Blood by Manual count
75-2 ceFAZolin [Susceptibility] by Minimum lethal concentration (MLC)
75149-5 Deoxyguanosine [Moles/volume] in Cerebrospinal Fluid
75327-7 Life expectancy [Time] Estimated
75585-0 Comment on fetal Prader-Willi syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
75773-2 Goals, preferences, and priorities for medical treatment Narrative - Reported
75997-7 Systolic blood pressure by Continuous non-invasive monitoring
76147-8 Cefovecin [Susceptibility] by Minimum inhibitory concentration (MIC)
7640-6 Pyrethrum triggered histamine release [Units/volume] in Blood
76565-1 Left ventricular Cardiac output by US.2D+Calculated
7681-0 Common Sagebrush IgE Ab [Units/volume] in Serum
77138-6 Chloride [Moles/volume] in Serum, Plasma or Blood
77343-2 Gamma globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration
77601-3 Enhanced note
77756-5 7-Aminoclonazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
77991-8 MMWR Week [CDC.PHIN]
78352-2 Vaccenate (C18:1w7) [Entitic substance] in Red Blood Cells
78789-5 Amoxapine [Mass/mass] in Hair
78943-8 Cardiac procedure complications panel
79180-6 Somatotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge
79342-2 Carnitine biosynthesis intermediates pattern [Interpretation] in Urine Narrative
79516-1 Octenedioate (C8:1) [Moles/volume] in Serum or Plasma
79685-4 5,6-Dihydrouracil/Creatinine [Molar ratio] in Urine
79830-6 Left eye Axis--W cycloplegia by Objective refraction
79982-5 Left atrial End-systolic volume (by US.2D+Calculated by biplane area-length method)/Body surface area
80127-4 Aluminum [Moles/volume] in Cerebrospinal Fluid
80283-5 Murmur radiating to body location [Anatomy] by Auscultation
80461-7 Dairy servings 24 hour Estimated
80627-3 Coagulation factor X activated inhibitor [Mass/volume] in Platelet poor plasma
80870-9 US for pregnancy limited
81015-0 Arginine intake 24 hour Estimated
81162-0 US Guidance for needle localization Breast - left and MG Views Breast specimen
81364-2 Religious or cultural beliefs Narrative - Reported
81586-0 NM Whole body Views W Y-90 ibritumomab tiuxetan IV
8177-8 Cannabinoids [Presence] in Unknown substance
81921-9 Lysine intake 24 hour Measured
82143-9 Did you live with anyone who used illegal street drugs or who abused prescription medications
8231-3 Phencyclidine [Mass/volume] in Meconium
82506-7 Oligosaccharides pattern [Interpretation] in Fibroblast by Screen method Narrative
82682-6 CT Clavicle - left WO contrast
82854-1 Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine
83033-1 XR Hip single view during surgery
83234-5 Prior device use during assessment period [CMS Assessment]
84900-0 Other nodule quadrant [Anatomy] in Prostate tumor
85345-7 Dermal lymph-vascular invasion in Cancer specimen Qualitative by Light microscopy
85569-2 Physical therapy - group minutes--week 2 [CMS Assessment]
85776-3 Proteus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture
86014-8 Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
86160-9 Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --2nd specimen
86320-9 Zika virus neutralizing antibody [Presence] in Specimen by Neutralization test
86518-8 Ebola virus RNA [Presence] in Blood by NAA with probe detection
86704-4 Lawsonia intracellularis RNA [Cycle Threshold #] in Specimen by NAA with probe detection
86866-1 MDS v3.0 - RAI v1.17.2 - Urinary toileting program - NP, NQ, SP during assessment period [CMS Assessment]
87056-8 Guidance for biopsy of Abdomen
87216-8 Date on existing record to be modified or inactivated during assessment period [CMS Assessment]
87418-0 Cytolethal distending toxin B Ab [Units/volume] in Serum by Immunoassay
87615-1 Sulfate [Mass/mass] in Specimen
87815-7 fentaNYL [Presence] in Saliva (oral fluid) by Screen method
87979-1 Fungus identified in Pleural fluid by Culture
88148-2 Microscopic observation [Identifier] in Genital specimen by Acid fast stain
88330-6 Mobility - admission performance during 3 day assessment period [CMS Assessment]
88546-7 Chlamydophila pneumoniae DNA [Presence] in Aspirate by NAA with probe detection
88733-1 Mi-2 beta Ab [Units/volume] in Serum by Line blot
89014-5 Oxygen was used for preoxygenation
89315-6 CD4+CD25+CD45RA+CD127Low+ cells [#/volume] in Blood
89533-4 SCL-70 extractable nuclear Ab [Presence] in Cerebrospinal Fluid by Line blot
89851-0 CTA Unspecified body region limited
90104-1 Emergency operations center standard operating procedure name
90442-5 Coxiella burnetii aroE gene [Presence] in Tissue by NAA with non-probe detection
90781-6 N,N'-dimethylarginine [Mass/volume] in Serum or Plasma
91017-4 Regional hospitals closed due to event or incident/Total regional hospitals
91542-1 Myelin oligodendrocyte glycoprotein Ab [Titer] in Cerebrospinal Fluid by Cell binding immunofluorescent assay
91795-5 Respiratory syncytial virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection
92045-4 Name of Donor
92555-2 Biophysical agent plan to use
92795-4 Candida guilliermondii DNA [Presence] by NAA with probe detection in Positive blood culture
92995-0 THBD gene full mutation analysis in Blood or Tissue by Sequencing
93229-3 LCDS v5.00 - Patient demographic information - admission during assessment period [CMS Assessment]
93422-4 Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebrospinal Fluid by Cell binding immunofluorescent assay
93656-7 Left ventricular Stroke volume by US.2D.A4C+Calculated by single plane method of disks
93835-7 Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
94025-4 Anxiety severity
94214-4 PRKAR1A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
94396-9 Influenza virus A H1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
94614-5 Bovine parainfluenza virus 3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
94827-3 Epstein Barr virus DNA [Presence] in Amniotic fluid by NAA with probe detection
94982-6 Placing telephone call - usual functional ability during assessment period [CMS Assessment]
95163-2 Infectious bronchitis virus Ab/Positive control in Serum by Immunoassay
95326-5 Corrective lens Spherical equivalent Calculated
95496-6 Other substances that you have had a strong desire or urge to use in the past 3 months [NIDA]
95666-4 Tahyna virus IgG Ab [Presence] in Specimen by Immunoassay
95842-1 Lymphocytes/Leukocytes in Sputum by Manual count
96060-9 Hematologic cancer
96271-2 DNA mismatch repair protein Msh3 Ag [Presence] in Cancer specimen by Immune stain
9645-3 Metanephrine/Creatinine [Mass Ratio] in Urine
96618-4 HLA-B [Type] in Donor by High resolution
96790-1 SOFA Total Score
96968-3 TNFAIP3 gene mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal
97130-9 How helpful has playing games with family members been as a coping strategy during the COVID-19 outbreak
97281-0 Morphine Free [Presence] in Cord tissue by Confirmatory method
97430-3 XR Finger third - right AP
97598-7 CD3-CD16+CD56+ (Natural killer) cells/Lymphocytes in Lower respiratory specimen by Flow cytometry (FC)
97818-9 Blood product volume and/or cell saver
97992-2 Herpes virus 6 IgM Ab [Presence] in Serum by Immunofluorescence
9816-0 Actinomyces sp identified in Specimen by Organism specific culture
98316-3 XR Knee - bilateral Single view W valgus stress
98469-0 Right eye Horizontal prism - in near by Phoropter
98698-4 Sensory nerve action potential amplitude Nerve
98844-4 Right eye Vertical prism - down for near fixation disparity by Phoropter
99008-5 Leptospira interrogans sv Djasiman Ab [Titer] in Serum by Agglutination
99176-0 OASIS E - Special Treatment, Procedures, and Programs - transfer to an inpatient facility during assessment period [CMS Assessment]
99365-9 Sheep milk IgG Ab [Mass/volume] in Serum
99526-6 Thickness [Length] of Right ventricle
99691-8 Pacemaker Ventricular sensitivity setting
99847-6 Frequency of producing verbal messages with appropriate form in low demand situations

End of sample. 500 of 85,065 codes are listed above; $expand the set against the terminology service for all of them.